TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF

作者: Giorgio Zauli , Erika Rimondi , Vanessa Nicolin , Elisabetta Melloni , Claudio Celeghini

DOI: 10.1182/BLOOD-2004-03-1196

关键词:

摘要: The role of the tumor necrosis factor (TNF) superfamily member receptor activator nuclear kappa B ligand (RANKL) in promoting differentiation osteoclasts has been extensively characterized. In this study, we have investigated effect TNF-related apoptosis-inducing (TRAIL), a TNF cytokines, osteoclastogenesis, by using human peripheral blood mononuclear cells and RAW264.7 murine monocytic cell line. Both models differentiate into osteoclast-like presence RANKL plus macrophage-colony-stimulating (M-CSF), as evaluated terms tartrate-resistant acid phosphatase (TRAP)-positive multinucleated bone resorption activity. Unexpectedly, when added culture combination with M-CSF, TRAIL inhibited osteoclastic both models. To investigate molecular mechanism underlining such inhibitory activity, analyzed on mitogen-activated protein kinases (MAPKs) pathways, which play key osteoclastogenesis. Treatment M-CSF activated ERK1/2 p38/MAPK are essential for proliferation preosteoclasts, respectively. Of note, addition to did not affect but it profoundly phosphorylation. Thus, our data demonstrate that blocks suggest inhibition pathway likely plays an important process. (Blood. 2004;104:2044-2050)

参考文章(44)
Henning Walczak, Robert E. Miller, Kiley Ariail, Brian Gliniak, Thomas S. Griffith, Marek Kubin, Wilson Chin, Jon Jones, Anne Woodward, Tiep Le, Craig Smith, Pam Smolak, Raymond G. Goodwin, Charles T. Rauch, JoAnn C.L. Schuh, David H. Lynch, Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine. ,vol. 5, pp. 157- 163 ,(1999) , 10.1038/5517
S. Amar, D. Cochran, T. Oates, D. T. Graves, R. Assuma, IL-1 and TNF Antagonists Inhibit the Inflammatory Response and Bone Loss in Experimental Periodontitis Journal of Immunology. ,vol. 160, pp. 403- 409 ,(1998)
Young-Yun Kong, Hiroki Yoshida, Ildiko Sarosi, Hong-Lin Tan, Emma Timms, Casey Capparelli, Sean Morony, Antonio J. Oliveira-dos-Santos, Gwyneth Van, Annick Itie, Wilson Khoo, Andrew Wakeham, Colin R. Dunstan, David L. Lacey, Tak W. Mak, William J. Boyle, Josef M. Penninger, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature. ,vol. 397, pp. 315- 323 ,(1999) , 10.1038/16852
Dirk M. Anderson, Eugene Maraskovsky, William L. Billingsley, William C. Dougall, Mark E. Tometsko, Eileen R. Roux, Mark C. Teepe, Robert F. DuBose, David Cosman, Laurent Galibert, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature. ,vol. 390, pp. 175- 179 ,(1997) , 10.1038/36593
Toshimi Michigami, Keiichi Ozono, Miwa Yamazaki, Miyuki Ihara-Watanabe, Receptor Activator of Nuclear Factor κB Ligand (RANKL) Is a Key Molecule of Osteoclast Formation for Bone Metastasis in a Newly Developed Model of Human Neuroblastoma Cancer Research. ,vol. 61, pp. 1637- 1644 ,(2001)
J. Li, I. Sarosi, X.-Q. Yan, S. Morony, C. Capparelli, H.-L. Tan, S. McCabe, R. Elliott, S. Scully, G. Van, S. Kaufman, S.-C. Juan, Y. Sun, J. Tarpley, L. Martin, K. Christensen, J. McCabe, P. Kostenuik, H. Hsu, F. Fletcher, C. R. Dunstan, D. L. Lacey, W. J. Boyle, RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 1566- 1571 ,(2000) , 10.1073/PNAS.97.4.1566
Nobuaki Nakagawa, Masahiko Kinosaki, Kyoji Yamaguchi, Nobuyuki Shima, Hisataka Yasuda, Kazuki Yano, Tomonori Morinaga, Kanji Higashio, RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochemical and Biophysical Research Communications. ,vol. 253, pp. 395- 400 ,(1998) , 10.1006/BBRC.1998.9788
Orhan Sezer, Ulrike Heider, Ivana Zavrski, Christian Alexander Kühne, Lorenz Christian Hofbauer, RANK ligand and osteoprotegerin in myeloma bone disease Blood. ,vol. 101, pp. 2094- 2098 ,(2003) , 10.1182/BLOOD-2002-09-2684
Nicola Giuliani, Régis Bataille, Cristina Mancini, Mirca Lazzaretti, Sophie Barillé, Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment Blood. ,vol. 98, pp. 3527- 3533 ,(2001) , 10.1182/BLOOD.V98.13.3527